Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clofazamine in the Long Term Treatment of Leprosy, Phase III

NCT00852345 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT00852345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00852345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clofazamine in the Long Term Treatment of Leprosy, Phase III
Lead sponsor
Kaiser Permanente
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leprosy